全自动OCS(光交换机)封装整线
Search documents
罗博特科:签订单笔金额约770.00万欧元日常经营重大合同
Jin Rong Jie· 2026-01-06 17:30
作者:公告君 罗博特科公告称,公司全资子公司ficonTEC Service GmbH近日与瑞士某头部公司C的子公司签署单笔金 额约770.00万欧元(折合人民币约6307.84万元)的合同,该金额占公司2024年度经审计营业收入的比例 超过5.70%,系ficonTEC与该客户签订的第二条全自动OCS(光交换机)封装整线订单。合同自双方签 字之日起生效,顺利履行预计将对公司本年度经营业绩产生积极影响,但在履行过程中如遇政策、市场 环境等不可预计或不可抗力因素,可能导致合同无法如期或全面履行。本次交易对手方信息及合同具体 细节因商业秘密已豁免披露,敬请广大投资者注意投资风险。 本文源自:市场资讯 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 ...
【公告全知道】商业航天+人形机器人+低空经济+军工+新能源车!公司商业航天火箭结构件业务已形成正式的合同订单
财联社· 2026-01-06 15:32
Group 1 - The article highlights significant announcements in the stock market, including "suspensions and resumption of trading, shareholding changes, investment wins, acquisitions, performance reports, unlocks, and high transfers" [1] - A company involved in commercial aerospace has established formal contract orders for rocket structural components, with major clients including Blue Arrow Aerospace, and has received small batch sample orders from clients like Zhiyuan Robotics [1] - Another company is focused on brain-computer interfaces, humanoid robots, multimodal AI, autonomous driving, AI chips, and cloud computing, and is optimizing its brain model while developing its own brain-computer interface system, having partnered with Leju Robotics to deliver a small number of robots equipped with the large model [1] - A company has signed a second fully automated OCS (Optical Switch) packaging production line order, indicating its involvement in commercial aerospace, chips, and CPO, with partnerships including Nvidia and Huawei HiSilicon [1]
晚间公告|1月6日这些公告有看头
Di Yi Cai Jing· 2026-01-06 15:15
Group 1 - Xinfeng Pharmaceutical is facing criminal charges for unit bribery, which may negatively impact its profits [2] - Aerospace Electronics has seen a stock price increase of 123.23% since November 27, 2025, significantly outpacing the industry and market, indicating potential irrational market behavior [3] - Chipone Technology has completed the acquisition of Zhudian Semiconductor, gaining a 40% stake and control over the company [4] Group 2 - Chaoying Electronics has increased its investment in AI high-end printed circuit board expansion from 1.468 billion to 3.315 billion yuan, with a production capacity target of 166,500 square meters annually [5] - Yihuilong's Brain Machine Star Chain is developing non-invasive brain-machine interface products, but they are still in early stages and not yet registered [6] - Aerospace Changfeng has confirmed it is not engaged in brain-machine interface or commercial aerospace businesses, despite being categorized as such [7] Group 3 - Guosheng Technology's stock will be suspended for trading on January 7, 2026, due to significant price fluctuations, with a cumulative increase of 370.20% since October 31, 2025 [9] - Xiangyu Medical focuses on non-invasive brain-machine interface technology, with no large-scale sales achieved yet, but aims to cover over 1,000 top-tier hospitals by 2026 [10] - Jiamai Packaging's stock has risen by 230.48% from December 17, 2025, leading to a trading suspension for review [11] Group 4 - Zhongtai Co. expects a net profit of 420 million to 480 million yuan for 2025, recovering from a loss of 77.96 million yuan in the previous year [19] - Lier Chemical anticipates a net profit increase of 113.62% to 132.19% for 2025, driven by rising product demand [20] - Pengding Holdings reported a 30.74% increase in consolidated revenue for December 2025, totaling 424.355 million yuan [21] Group 5 - Times New Materials signed a sales contract for wind turbine blades worth approximately 3.32 billion yuan [31] - Jinggong Steel Structure won a bid for a project worth 824 million yuan, representing 4.46% of its latest audited revenue [32] - Robotech's subsidiary ficonTEC signed a significant contract worth approximately 7.7 million euros for automated optical switch packaging [33]